Akèy › Limfangyoleyomiomatoz › New York
Etid klinik pou Limfangyoleyomiomatoz nan New York
3 etid pou Limfangyoleyomiomatoz ap chèche patisipan nan sit nan New York.
Tèks ofisyèl etid la (Anglè)
TSC Biosample Repository and Natural History Database
- New York University Medical Center, New York
- University of Rochester Medical Center, Rochester
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jun 24, 2026 · NCT05676099Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)
- Columbia University Irving Medical Center, New York
Ap rekriteFaz 1
Laj 18 a 64 · Fanm · Mizajou Jan 21, 2026 · NCT06889168Safety and Durability of Sirolimus for Treatment of LAM
- University of Rochester Medical Center, Rochester
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Fanm · Mizajou Dec 24, 2024 · NCT02432560Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.